Counseling Women with NIPT Results Suggesting Cancer
This study by Giles et al. (Prenatal Diagnosis, 2016) surveyed genetic counselors on their current methods and management needs for counseling women whose prenatal cfDNA screening indicate maternal neoplasm.
Anonymous Online Survey Answered by Board-Eligible/Certified Genetic Counselors through the NSGC.
343 participants completed the entire survey. Despite the fact that 95% of participants previously knew that NIPT could be used to uncover maternal neoplasm, the majority (51.8%) did not feel adequately prepared or comfortable discussing the ramifications of a test report suggesting an increased risk for maternal neoplasm based on NIPT findings. This study substantiates the urgent need for management guidelines on this topic.
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan